About Us Direct to You Research Archives Currencies Shares Media
Monitoring Home

PRODUCT PROFILE

Latest Dublin Prices

NAME	LATEST	CHANGE
Aer Lingus	1.60	-0.02	more
BoI	0.16	0.01	more
CRH	15.48	-0.15	more
Elan	10.13	0.05	more
Glanbia	10.15	0.04	more
Grafton	5.59	-0.07	more
Greencore	0.64	-0.02	more
Ind. News	0.12	0.01	more
Ryanair	6.85	0.04	more

Shares in full

Eli Lilly profits hit by generic drugs

Tuesday, January 29 11:59:44

Eli Lilly and Co said today that fourth-quarter earnings had fallen as competition from generic drugs drove revenue lower.

The U.S. drugmaker said it had earned $827 million, or 74 cents per share, compared with $858 million, or 77 cents per share, a year earlier.

Excluding special items such as asset impairments, restructuring and other special charges, Lilly earned 85 cents per share. Analysts on average were expecting 78 cents per share.

Business World is a service of Media World Ltd. All rights reserved. While every effort has been made to ensure the accuracy of the data provided, neither Media World Ltd nor its agents or representatives will be responsible for any loss or damage on the part of users however caused. The service is for entertainment only, and no decisions, particularly investment decisions, should be taken on the basis of information supplied in the service.